Background Privatisation and private sector practices have been increasingly applied to the public sector in many industrialised countries. Over the same period, long-term work disability has risen substantially. We examined whether a major organisational change—the transfer of public sector work to executive agencies run on private sector lines—was associated with an increased risk of work disability.
Methods The study uses self-reported data from the prospective Whitehall II cohort study. Associations between transfer to an executive agency assessed at baseline (1991–1994) and work disability ascertained over a period of approximately 8 years at three follow-up surveys (1995–1996, 1997–1999 and 2001) were examined using Cox proportional hazard models.
Results In age- and sex-adjusted models, risk of work disability was higher among the 1263 employees who were transferred to an executive agency (HR 1.90, 95% CI 1.46 to 2.48) compared with the 3419 employees whose job was not transferred. These findings were robust to additional adjustment for physical and mental health and health behaviours at baseline.
Conclusions Increased work disability was observed among employees exposed to the transfer of public sector work to executive agencies run on private sector lines. This may highlight an unintentional cost for employees, employers and society.
- Disability SI
- employed C
- epidemiology FQ
Statistics from Altmetric.com
Funding The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. JEF is supported by the Medical Research Council (grant G8802774), MK, JV, TNA and MV by the Academy of Finland (grants 117604, 124271, 124322, 129262 and 133535), MK is also supported by the BUPA Foundation, UK, and the NIH/National Heart, Lung, and Blood Institute (R01HL036310-20A2) and the National Institute on Aging (R01AG034454), USA; ASM is supported by a “EURYI” award from the European Science Foundation and the National Institute on Aging (R01AG013196 and R01AG034454), MGM by an MRC Research Professorship and MJS by a grant from the British Heart Foundation.
Competing interests None.
Ethics approval This study was conducted with the approval of the University College London Medical School committee on the ethics of human research.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.